200 105590 advanced:3.55891312765391 year:1.51122028428865 clipping:3.24045939653538 reason:3.55891312765391 cancer:4.63203032133495 case:0.325148690291958 part:4.02891675689965 cohort:2.32203570971108 investigators:1.68711095075232 control:0.919855798038651 design:2.29943659920322 draw:1.80971327284465 grow:0.802072762382268 study:1.94947521521981 eric:4.53974238066564 study:0.90215622093925 figure:1.80971327284465 men:2.38025813131226 follow:3.06970245747747 men:2.38025813131226 gonna:3.55891312765391 entire:3.15344801954575 biological:0.60791674794131 health:4.04368568455605 free:1.44869992730732 questionnaire:2.27105883934727 year:0.675510039073838 started:1.66806275578162 50000:3.84659520010569 levels:2.14801295573182 lorelei:4.53974238066564 specimens:2.74798291143758 1986:5.44675420127076 mucci:4.25206030821386 source:8.50412061642772 nested:2.93030446823154 nail:1.0844777777332 factors:0.867670044868081 professionals:10.3233902759926 prostate:7.69319040021138 invited:2.74798291143758 interesting:0.834333624600489 levels:1.49521994294221 remember:0.417998844255421 researchers:3.89895043043962 rimm:4.53974238066564 risk:0.614474148487469 selenium:3.84659520010569 toenails:2.54731221597543 previous:3.69244452027843 started:1.49601108222398 study:3.25622459105828 biomarkers:1.71846235244443 talk:0.84683782344952 thought:3.84956520525888 thought:16.1156670275986 undertook:4.53974238066564 men:1.4551892245079
105590 212740 ed:7.11782625530782 giovannucci:3.24045939653538 hypothesis:0.489454245962768 study:1.28164584264415 ended:4.63203032133495 case:1.62574345145979 hypothesis:7.69319040021138 1996:1.68711095075232 control:2.75956739411595 risk:0.87618073453599 1987:14.8356224663214 nested:0.802072762382268 case:1.02323415249249 measure:3.84659520010569 ed:4.9452074887738 study:3.80672045060016 sampling:1.83169217956343 1987:9.8904149775476 funds:1.07400647786591 wanted:1.66806275578162 controls:0.810040932031445 set:0.526366880977203 collection:0.793215308548206 study:2.72337710063538 nested:5.86060893646308 select:0.153557735843091 study:1.57791165878733 1994:1.78820706762369 population:0.514390689930487 1996:11.5397856003171 randomized:2.38025813131226 study:1.17244655067916 clark:1.38985942728439 cases:0.417998844255421 cases:1.84342244546241 1987:0.668541369757745 advanced:1.44869992730732 toenails:7.69319040021138 occurred:0.75132896085772 source:2.54731221597543 hypothesis:2.99929733971849 study:2.66418375632041 identified:0.0700101655726489 study:8.0578335137993 referred:1.54401010711165 measure:9.07948476133128 back:0.956223442209526
212740 302470 men:7.11782625530782 cancer:0.550758334101362 skin:4.63203032133495 case:0.650297380583916 results:1.14971829960161 larry:3.84659520010569 find:1.26881672677657 control:2.75956739411595 chance:2.11199414471758 number:1.75236146907198 results:2.41947884446554 levels:0.748005541111992 researchers:0.778542264972074 professionals:3.06970245747747 study:3.5343073168517 men:2.6957904563707 found:3.15344801954575 found:4.9452074887738 measured:3.22201943359773 relative:0.984394319176222 selenium:1.47947158597407 cancer:3.44113009199753 men:0.793215308548206 men:4.53974238066564 37000:8.17013130190614 nested:5.86060893646308 years:0.153557735843091 controls:0.984394319176222 trial:1.7263316639056 source:0.514390689930487 health:6.88226018399506 develop:7.69319040021138 paper:0.520360856916991 clark:2.34489310135832 calculate:0.654748047625409 randomized:1.52748080516043 ratios:4.68503560665884 specimen:1.94947521521981 compare:1.26881672677657 risk:2.45789659394988 sampling:0.668541369757745 selected:1.44869992730732 toenails:7.69319040021138 set:0.37566448042886 melanoma:3.69244452027843 cancer:2.54731221597543 toenail:3.69244452027843 study:1.18408166947574 read:0.42341891172476 study:16.1156670275986 randomized:3.0880202142233 levels:0.970126149671934
302470 398380 question:2.14184710786727 case:7.11782625530782 authors:3.24045939653538 address:0.550758334101362 prostate:4.63203032133495 case:1.30059476116783 cohort:2.32203570971108 bit:2.4603008389858 conducted:2.54731221597543 control:3.6794231921546 critiquing:3.44113009199753 risk:1.68711095075232 sampling:1.14971829960161 participant:6.67225102312648 question:1.9747930232041 diagnosed:5.73153189418792 question:1.29454924748006 researchers:1.83169217956343 1990:0.396607654274103 cohort:2.69391569016731 nested:2.93030446823154 potential:0.153557735843091 discuss:7.69913041051776 number:0.582108863985438 source:0.514390689930487 participant:2.95894317194814 complex:2.80514132527753 advanced:11.5397856003171 question:4.16288685533593 diagnosed:1.28164584264415 design:1.94947521521981 principles:2.45789659394988 set:2.00562410927323 question:3.84659520010569 risk:1.12699344128658 control:2.54731221597543 study:1.18408166947574 thinking:1.83169217956343
398380 489410 years:1.70652903660942 concerned:5.9243790696123 limitations:2.64262239577975 case:0.325148690291958 categorize:2.59383223161032 undertaken:0.634408363388287 complicated:2.59383223161032 core:1.92478260262944 finally:2.08300660784433 continuous:1.49521994294221 compare:3.3357695763397 exposure:4.25206030821386 divided:0.725699783597694 concepts:1.43366204994278 equal:0.462204936759917 risk:0.748005541111992 exposure:6.4727462374003 exposure:2.4390281230743 study:0.778542264972074 estimate:3.55891312765391 influence:2.34251780332942 groups:0.249282939517245 happened:0.60791674794131 recently:5.84842564565943 influence:1.52748080516043 levels:1.07400647786591 potential:1.66806275578162 measure:1.58643061709641 oftentimes:9.8904149775476 findings:2.95894317194814 question:1.56108257075097 quintiles:4.53974238066564 reflect:3.07340531187221 reflect:2.99043988588442 influence:2.34251780332942 epidemiology:2.5632916852883 relative:0.614474148487469 selenium:7.69319040021138 simply:2.59383223161032 study:0.888061252106805 relates:3.07340531187221 things:0.209009040379305 study:4.53974238066564 window:2.38025813131226 20:0.485063074835967 yesno:4.25206030821386
489410 583700 cancer:3.55891312765391 chemo:2.93030446823154 cancer:1.70652903660942 secondary:1.14971829960161 found:1.11656609228471 selenium:2.1689555554664 undertaken:1.00362568110411 studies:3.55891312765391 selenium:1.40424816473649 time:0.281768394661733 risk:10.8080707497815 selenium:4.9452074887738 clark:3.84659520010569 prostate:0.634408363388287 epidemiological:2.54731221597543 based:0.231182897873627 randomized:1.14971829960161 healthy:2.64262239577975 randomized:4.83895768893108 diagnosis:3.44113009199753 average:1.02323415249249 1996:3.5343073168517 men:2.64262239577975 national:3.3357695763397 blood:2.99929733971849 larry:4.9452074887738 association:1.07400647786591 selenium:1.47947158597407 analysis:4.08506565095307 years:2.4603008389858 men:5.0057209068092 thinking:1.47947158597407 potential:5.18766446322064 prostate:2.38025813131226 lower:19.2329760005284 published:4.76051626262452 randomized:4.68978620271664 called:1.87715455364018 primary:3.07340531187221 60:1.84342244546241 found:4.02891675689965 undertook:2.89739985461464 randomized:26.9261664007398 trail:1.29454924748006 35000:1.41884696415764 study:2.07214292158254 prostate:1.83169217956343 states:0.0700101655726489 biomarkers:4.02891675689965 trial:4.9452074887738 study:1.54401010711165 study:9.07948476133128 cancer:4.53974238066564 recruited:1.70652903660942 design:5.99859467943698 prostate:0.970126149671934
583700 654100 question:2.02743675668952 forward:0.538488241509547 association:1.11656609228471 confounding:1.9747930232041 cancer:3.0880202142233 clark:3.84659520010569 providing:2.86576594709396 question:0.634408363388287 study:1.9747930232041 study:2.08300660784433 explanations:1.36168855031769 contrast:3.3357695763397 randomized:1.8397115960773 study:6.88226018399506 advantages:2.99929733971849 protective:0.96552583487184 epidemiological:7.25843653339662 found:1.87715455364018 plausible:2.38025813131226 interpretation:1.29454924748006 study:1.21951406153715 question:2.30615015915854 found:3.5343073168517 cancer:2.64262239577975 bias:1.52748080516043 larry:4.9452074887738 questions:3.24045939653538 post:2.34251780332942 exposure:0.654748047625409 letting:1.0844777777332 concerned:3.44113009199753 answers:2.86576594709396 supplementation:2.59383223161032 prostate:7.69319040021138 evidence:3.07340531187221 logging:2.05483573087764 guess:2.08144342766796 randomization:3.51733965203748 relative:2.34251780332942 results:0.634408363388287 risk:1.22894829697494 selenium:7.69319040021138 studies:1.77612250421361 selenium:3.69244452027843 comments:1.92478260262944 control:1.54401010711165
